Crossmark

Simultaneous UHPLC-PDA Method Development and Validation for Quantification of Quercetin and Erlotinib in Liquid Crystalline Nanoparticle Formulation and Pharmacokinetic Study

Crossref DOI link: https://doi.org/10.1007/s10337-024-04355-7

Published Online: 2024-08-08

Published Print: 2024-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kothuri, Naresh

Verma, Sonia

JVUS, Chakradhar

Singh, Sanjay

Yadav, Pooja

Yadav, Pavan Kumar

Kashyap, Amit

Tiwari, Amrendra

Sharma, Deepak

Chourasia, Manish Kumar
Funding

Funding for this research was provided by:

Indian Council of Medical Research

Department of Science and Technology, Ministry of Science and Technology, India
License Information

Text and Data Mining valid from 2024-08-08

Version of Record valid from 2024-08-08
More Information

Article History

Received: 10 May 2024

Revised: 15 July 2024

Accepted: 31 July 2024

First Online: 8 August 2024

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below